Laure Gossec to Humans
This is a "connection" page, showing publications Laure Gossec has written about Humans.
Connection Strength
0.148
-
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries. Arthritis Care Res (Hoboken). 2020 12; 72(12):1772-1779.
Score: 0.007
-
Criteria for inclusion in programs of functional restoration for chronic low back pain: Pragmatic Study. Ann Phys Rehabil Med. 2020 May; 63(3):189-194.
Score: 0.007
-
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale. J Rheumatol. 2019 10; 46(10):1259-1267.
Score: 0.007
-
Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis. Clin Rheumatol. 2018 Oct; 37(10):2649-2657.
Score: 0.006
-
Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review. Adv Rheumatol. 2018 May 24; 58(1):1.
Score: 0.006
-
Quality of life in psoriatic arthritis. Expert Rev Clin Immunol. 2018 05; 14(5):405-417.
Score: 0.006
-
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients. Clin Rheumatol. 2018 Jun; 37(6):1503-1510.
Score: 0.006
-
The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries. Rheumatology (Oxford). 2018 02 01; 57(2):300-308.
Score: 0.006
-
Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature. J Rheumatol. 2018 01; 45(1):6-13.
Score: 0.006
-
Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Ann Rheum Dis. 2018 02; 77(2):258-263.
Score: 0.006
-
Response to: 'The GRAPPA-OMERACT initiative to standardise outcomes in Psoriatic Arthritis clinical trials and longitudinal observational studies' by Tillet et al. Ann Rheum Dis. 2018 05; 77(5):e24.
Score: 0.006
-
How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review. Ann Rheum Dis. 2018 05; 77(5):782-783.
Score: 0.006
-
Primary inefficacy of TNF inhibitors in patients with axial spondyloarthritis: a long-term follow-up of 25 patients. Rheumatology (Oxford). 2017 06 01; 56(6):896-900.
Score: 0.006
-
Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial. Clin Exp Rheumatol. 2017 Sep-Oct; 35(5):786-790.
Score: 0.006
-
Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis. Clin Rheumatol. 2017 May; 36(5):1149-1154.
Score: 0.006
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.002
-
EULAR COVID-19 registry: lessons learnt and future considerations. Ann Rheum Dis. 2021 09; 80(9):1110-1115.
Score: 0.002
-
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942.
Score: 0.002
-
How COVID-19 is changing rheumatology clinical practice. Nat Rev Rheumatol. 2021 01; 17(1):11-15.
Score: 0.002
-
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR). Rheumatology (Oxford). 2020 07 01; 59(7):1495-1504.
Score: 0.002
-
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020 07; 79(7):851-858.
Score: 0.002
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866.
Score: 0.002
-
Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis. Rheumatology (Oxford). 2020 01 01; 59(1):84-89.
Score: 0.002
-
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients. J Rheumatol. 2020 06 01; 47(6):854-864.
Score: 0.002
-
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases. RMD Open. 2019; 5(2):e001014.
Score: 0.002
-
Psychometric properties and cross-language equivalence of the revised Bristol Rheumatoid Arthritis Fatigue and the Rheumatoid Arthritis Impact of Disease scales in rheumatoid arthritis. Qual Life Res. 2019 Sep; 28(9):2543-2552.
Score: 0.002
-
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1014-1020.
Score: 0.002
-
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. J Rheumatol. 2019 08; 46(8):1021-1027.
Score: 0.002
-
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. J Rheumatol. 2019 08; 46(8):1028-1035.
Score: 0.002
-
Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients. Clin Exp Rheumatol. 2019 Jan-Feb; 37(1):26-31.
Score: 0.002
-
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials. J Rheumatol. 2019 08; 46(8):990-995.
Score: 0.002
-
The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France. Adv Rheumatol. 2018 Oct 22; 58(1):33.
Score: 0.002
-
The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch Models. Qual Life Res. 2018 Nov; 27(11):2909-2921.
Score: 0.002
-
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications. Ann Rheum Dis. 2018 12; 77(12):1835-1836.
Score: 0.002
-
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. Arthritis Res Ther. 2018 06 19; 20(1):129.
Score: 0.002
-
Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis. Ann Rheum Dis. 2018 08; 77(8):1099-1106.
Score: 0.002
-
The controversy of using PGA to define remission in RA. Nat Rev Rheumatol. 2018 03 21; 14(4):245.
Score: 0.002
-
Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice-Based Call for a Paradigm Change. Arthritis Care Res (Hoboken). 2018 03; 70(3):369-378.
Score: 0.002
-
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Ann Rheum Dis. 2018 04; 77(4):476-479.
Score: 0.001
-
The impact of patient global assessment in the definition of remission as a predictor of long-term radiographic damage in patients with rheumatoid arthritis: protocol for an individual patient data meta-analysis. Acta Reumatol Port. 2018 Jan-Mar; 43(1):52-60.
Score: 0.001
-
Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann Rheum Dis. 2018 04; 77(4):533-540.
Score: 0.001
-
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Ann Rheum Dis. 2018 Jan; 77(1):124-127.
Score: 0.001
-
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Semin Arthritis Rheum. 2018 04; 47(5):654-665.
Score: 0.001
-
Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients. Rheumatology (Oxford). 2017 09 01; 56(9):1573-1578.
Score: 0.001
-
New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. Rheumatology (Oxford). 2017 08 01; 56(8):1251-1253.
Score: 0.001
-
Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting. J Rheumatol. 2017 Oct; 44(10):1544-1550.
Score: 0.001
-
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016. J Rheumatol. 2017 Dec; 44(12):1889-1893.
Score: 0.001
-
Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets. J Rheumatol. 2017 Oct; 44(10):1551-1559.
Score: 0.001
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017 Jun; 76(6):960-977.
Score: 0.001
-
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. J Rheumatol. 2017 Oct; 44(10):1522-1528.
Score: 0.001
-
Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011 Apr; 63(4):557-63.
Score: 0.001